# Atrium Therapeutics, Inc.: Form 8-K, filed Aug 13, 2026

- Company: [Atrium Therapeutics, Inc.](/companies/rna.md) (CIK 2093101)
- Form: 8-K
- Filed: 2026-08-13
- Accepted by EDGAR: Aug 13, 2026, 16:50 ET
- Period: 2026-08-13
- Accession: 0001193125-26-349482
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2093101/000119312526349482/d149126d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2093101/000119312526349482/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2093101/000119312526349482/d149126d8k.htm

Filed Aug 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-349482. Last ingested by Listed: Nov 2, 2026, 06:48 ET. No prices; not investment advice.